Journal article
Gold‐standard evidence and best practice guidance for menstrual cycle‐informed clinical care: An overview for clinicians
- Abstract:
- Objectives: To synthesize current evidence and provide clinically actionable recommendations for integrating menstrual cycle‐related processes—particularly hormone sensitivity, Premenstrual Dysphoric Disorder (PMDD) and Premenstrual Exacerbation (PME)—into psychological assessment, formulation and treatment. Design: Narrative, clinically oriented review. Methods: We integrated findings from experimental, longitudinal and clinical studies on menstrual cycle physiology, hormone sensitivity, PMDD and PME, with a focus on evidence relevant to psychological practice. Emphasis was placed on gold‐standard methodologies (e.g., prospective symptom assessment, biologically anchored cycle phase determination) and on translational relevance for clinical decision‐making. Results: A substantial minority of naturally cycling individuals show sensitivity to normative hormonal fluctuations, resulting in clinically significant distress or impairment. PMDD affects approximately 3–8% of menstruating individuals and is characterissed by severe, luteal‐phase–specific symptoms and elevated suicidality risk. PME appears even more prevalent, affecting up to 50–60% of individuals with mood disorders. Despite this, menstrual cycle‐related symptom patterns are rarely assessed or incorporated into routine care. The literature supports several key clinical strategies: (1) prospective daily symptom tracking across at least two menstrual cycles; (2) cycle‐informed case formulations integrating timing and symptom expression; and (3) adaptation of evidence‐based interventions to predictable cyclical patterns. Clinician‐ready tools and case‐based approaches facilitate implementation. Conclusions: The menstrual cycle represents a clinically meaningful yet underrecognized source of within‐person variability in mental health. Integrating cycle‐informed approaches into psychological care can enhance diagnostic precision, improve personalized formulations and optimize treatment outcomes for individuals affected by PMDD and PME.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 2.4MB, Terms of use)
-
- Publisher copy:
- 10.1111/bjc.70066
Authors
- Publisher:
- Wiley
- Journal:
- British Journal of Clinical Psychology More from this journal
- Article number:
- bjc.70066
- Publication date:
- 2026-05-20
- Acceptance date:
- 2026-04-24
- DOI:
- EISSN:
-
2044-8260
- ISSN:
-
0144-6657
- Language:
-
English
- Keywords:
- Source identifiers:
-
4066556
- Deposit date:
-
2026-05-21
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2026
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record